Question 1

What is the catalog number for 2 pieces disposable syringe,5 ML (6 ML) Luer centric bulk?

Accepted Answer

The catalog number for 2 pieces disposable syringe,5 ML (6 ML) Luer centric bulk is SYRITGWOST05LLBA.

Question 2

What sizes are available for 2 pieces disposable syringe,5 ML (6 ML) Luer centric bulk?

Accepted Answer

2 pieces disposable syringe,5 ML (6 ML) Luer centric bulk is available in the following size(s): 2400 Pieces/Case:100 Pieces/ PACKS:24 PACKS/CASE.

Question 3

Is 2 pieces disposable syringe,5 ML (6 ML) Luer centric bulk in stock?

Accepted Answer

2 pieces disposable syringe,5 ML (6 ML) Luer centric bulk is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What host species was used to raise this antibody?

Accepted Answer

The host species used in production is listed under product specifications on the datasheet, and is relevant when selecting a compatible secondary antibody for your assay.

Question 5

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 6

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

2 pieces disposable syringe,5 ML (6 ML) Luer centric bulk

Product Specifications

MOQ

HS Code

Shelf Life

Gross Weight

Volumetric Weight

Sterility

Frequently Asked Questions

Explore Other Products

[1,4'-Bipiperidine]-4'-carboxamide Dihydrochloride

Stackable CO2 Incubator Shaker

Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/2375), CF488A conjugate, 0.1mg/mL

S-Benzyl-L-homocysteine

TPM1 (NM_001018020) Human Over-expression Lysate

SLC4A10 Human Gene Knockout Kit (CRISPR)